Simons FE - Search Results

1

Fast-disintegrating sublingual epinephrine tablets: effect of tablet dimensions on tablet characteristics.

Rawas-Qalaji MM, Simons FE, Simons KJ. Rawas-Qalaji MM, et al. Among authors: simons fe, simons kj. Drug Dev Ind Pharm. 2007 May;33(5):523-30. doi: 10.1080/03639040600897150. Drug Dev Ind Pharm. 2007. PMID: 17520443

2

Is epinephrine administration by sublingual tablet feasible for the first-aid treatment of anaphylaxis? A proof-of-concept study.

Gu X, Simons KJ, Simons FE. Gu X, et al. Among authors: simons kj, simons fe. Biopharm Drug Dispos. 2002 Jul;23(5):213-6. doi: 10.1002/bdd.312. Biopharm Drug Dispos. 2002. PMID: 12116053

3

Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine.

Gu X, Fediuk DJ, Simons FE, Simons KJ. Gu X, et al. Among authors: simons fe, simons kj. Drug Dev Ind Pharm. 2004;30(10):1009-17. doi: 10.1081/ddc-200040237. Drug Dev Ind Pharm. 2004. PMID: 15595567

4

Hydroxyzine- and cetirizine-loaded liposomes: effect of duration of thin film hydration, freeze-thawing, and changing buffer pH on encapsulation and stability.

Elzainy AA, Gu X, Simons FE, Simons KJ. Elzainy AA, et al. Among authors: simons fe, simons kj. Drug Dev Ind Pharm. 2005 Mar;31(3):281-91. doi: 10.1081/ddc-52070. Drug Dev Ind Pharm. 2005. PMID: 15830724

5

Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis.

Rawas-Qalaji MM, Simons FE, Simons KJ. Rawas-Qalaji MM, et al. Among authors: simons fe, simons kj. J Allergy Clin Immunol. 2006 Feb;117(2):398-403. doi: 10.1016/j.jaci.2005.12.1310. J Allergy Clin Immunol. 2006. PMID: 16461140

6

Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.

Rawas-Qalaji MM, Simons FE, Simons KJ. Rawas-Qalaji MM, et al. Among authors: simons fe, simons kj. AAPS PharmSciTech. 2006 Apr 28;7(2):E41. doi: 10.1208/pt070241. AAPS PharmSciTech. 2006. PMID: 16796358 Free PMC article.

7

Epinephrine for the treatment of anaphylaxis: do all 40 mg sublingual epinephrine tablet formulations with similar in vitro characteristics have the same bioavailability?

Rawas-Qalaji MM, Simons FE, Simons KJ. Rawas-Qalaji MM, et al. Among authors: simons fe, simons kj. Biopharm Drug Dispos. 2006 Dec;27(9):427-35. doi: 10.1002/bdd.519. Biopharm Drug Dispos. 2006. PMID: 17009337

8

Epinephrine and its use in anaphylaxis: current issues.

Simons KJ, Simons FE. Simons KJ, et al. Among authors: simons fe. Curr Opin Allergy Clin Immunol. 2010 Aug;10(4):354-61. doi: 10.1097/ACI.0b013e32833bc670. Curr Opin Allergy Clin Immunol. 2010. PMID: 20543673 Review.

9

Dissolution testing of sublingual tablets: a novel in vitro method.

Rachid O, Rawas-Qalaji M, Simons FE, Simons KJ. Rachid O, et al. Among authors: simons fe, simons kj. AAPS PharmSciTech. 2011 Jun;12(2):544-52. doi: 10.1208/s12249-011-9615-0. Epub 2011 Apr 27. AAPS PharmSciTech. 2011. PMID: 21523516 Free PMC article.

10

Rapidly-disintegrating sublingual tablets of epinephrine: role of non-medicinal ingredients in formulation development.

Rachid O, Rawas-Qalaji M, Simons FE, Simons KJ. Rachid O, et al. Among authors: simons fe, simons kj. Eur J Pharm Biopharm. 2012 Nov;82(3):598-604. doi: 10.1016/j.ejpb.2012.05.020. Epub 2012 Jun 7. Eur J Pharm Biopharm. 2012. PMID: 22683694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters